J. Lamarck Asset Management

J. Lamarck Asset Management is a specialized boutique investment and financial advisory firm focused exclusively on the global biotechnology and healthcare sectors. With roots dating back to 1996 in Italy and its current headquarters in Lugano, Switzerland, the firm manages several dedicated healthcare funds, including the J. Lamarck Biotech and J. Lamarck Pharma sub-funds under the Selectra Investments SICAV. The company employs a rigorous investment strategy that combines deep scientific research and fundamental financial analysis to identify high-potential innovators, from small-cap biotech pioneers to established pharmaceutical leaders. Its focus areas include transformative medical technologies such as gene editing, CRISPR, and personalized medicine, aiming to capitalize on breakthroughs that address significant unmet medical needs. As an independent advisor, J. Lamarck provides strategic investment solutions to both private and institutional clients worldwide.